Ototoxicity and Teprotumumab

Highland, J; Gordon, S; Reddy, D; Patel, N

Patel, N (通讯作者),Univ Utah, Div Otolaryngol Head & Neck Surg, 50 North Med Dr,Room 3C120, Salt Lake City, UT 84132 USA.

ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2022; 131 (8): 910

Abstract

Objectives: Teprotumumab, a novel monoclonal antibody, targets the insulin-like growth factor 1 (IGF-1) receptor. IGF-1 receptors, found in muscle and......

Full Text Link